Desq Long
Sign in
SEC FORM 4
$2,755,980.80

Opus Genetics, Inc. (IRD)

Sale of 556,000 shares at $4.9568 per share.

Reporting Persons Foundation Fighting Blindness Retinal Degeneration Fund · Foundation Fighting Blindness, Inc. · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0002042266-26-000002 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Opus Genetics, Inc. (IRD)." Disclosed 2026-10-02. https://desqlong.com/cards/0002042266-26-000002-1 (retrieved 2026-10-03).